COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean

Virtual Health Sciences Library

  • Home
  • Search
  • Knowledge Base
  • Get a journal indexed in the Index Medicus
  • MyVHSL
  1. Home
  2. IMEMR
  3. Search Result
  4. Therapeutic applications of botulinum neurotoxins in head and neck disorders

Therapeutic applications of botulinum neurotoxins in head and neck disorders

Authors

Alshadwi Ahmad
Nadershah, Mohammed
Osborn, Timothy
Boston University Henry M. Goldman ; , School of Dental Medicine ; King Feisal Specialist Hospital and Research Centre, Department of Oral and Maxillofacial Surgery ;

Saudi Dent. J. 2015; 27 (1): 3-11
SDJ-Saudi Dental Journal [The]
Journal Country: Saudi Arabia
P-ISSN: 1013-9052
E-ISSN: 1658-3558
Type of Publication: Review
Category: Humans,
Type of Research: Clinical
Keywords: Botulinum Toxins / therapeutic use
Broad Subjects: Health Systems, Botulinum Toxins ,Pharmacology ,Botulinum Toxins ,Drug Effects ,Head ,Pathology ,Neck ,Pathology ,Temporomandibular joint Disorders ,Dystonia ,Facial Pain
Citation: Ahmad Alshadwi ,Mohammed Nadershah ,Timothy Osborn , Therapeutic applications of botulinum neurotoxins in head and neck disorders, Saudi Dent. J. 2015; 27 (1): 3-11

Abstract English

The aim of this article is to review the mechanism of action, physiological effects, and therapeutic applications of botulinum neurotoxins in the head and neck area. An extensive literature search was performed using keywords. The resulting articles were analyzed for relevance in four areas: overview on botulinum neurotoxins, the role of botulinum neurotoxins in the management of salivary secretory disorders, the role of botulinum neurotoxins in the management of facial pain, and the role of botulinum neurotoxins in head and neck movement disorders. Institutional review board approval was not needed due the nature of the study. Botulinum neurotoxin therapy was demonstrated to be a valuable alternative to conventional medical therapy for many conditions affecting the head and neck area in terms of morbidly, mortality, and patient satisfaction with treatment outcomes. Botulinum neurotoxin therapy provides viable alternatives to traditional treatment modalities for some conditions affecting the head and neck region that have neurological components. This therapy can overcome some of the morbidities associated with conventional therapy. More research is needed to determine the ideal doses of botulinum neurotoxin to treat different diseases affecting the head and neck regions

Full Text English

Subscribe to VHSL Newsletters

© 2020 WHO – EMRO